| __timestamp | Amgen Inc. | PTC Therapeutics, Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4422000000 | 79838000 |
| Thursday, January 1, 2015 | 4227000000 | 121816000 |
| Friday, January 1, 2016 | 4162000000 | 117633000 |
| Sunday, January 1, 2017 | 4069000000 | 4577000 |
| Monday, January 1, 2018 | 4101000000 | 12670000 |
| Tuesday, January 1, 2019 | 4356000000 | 12135000 |
| Wednesday, January 1, 2020 | 6159000000 | 18942000 |
| Friday, January 1, 2021 | 6454000000 | 32328000 |
| Saturday, January 1, 2022 | 6406000000 | 44678000 |
| Sunday, January 1, 2023 | 8415000000 | 65486000 |
| Monday, January 1, 2024 | 12858000000 |
Unleashing insights
In the ever-evolving pharmaceutical industry, understanding cost structures is crucial for investors and stakeholders. This analysis compares the cost of revenue for Amgen Inc. and PTC Therapeutics, Inc. over a decade, from 2014 to 2023. Amgen, a biotech giant, consistently shows a robust cost of revenue, peaking at approximately $8.4 billion in 2023, reflecting a 90% increase from 2014. In contrast, PTC Therapeutics, a smaller player, exhibits a more volatile trend, with costs fluctuating significantly, peaking at around $121 million in 2015 before dropping to $6.5 million in 2023. This stark contrast highlights Amgen's stable growth and PTC's dynamic cost management challenges. Such insights are invaluable for understanding the financial health and strategic positioning of these companies in the competitive biotech landscape.
Comparing Cost of Revenue Efficiency: Novo Nordisk A/S vs PTC Therapeutics, Inc.
AbbVie Inc. vs Amgen Inc.: Efficiency in Cost of Revenue Explored
Analyzing Cost of Revenue: AstraZeneca PLC and PTC Therapeutics, Inc.
Cost of Revenue Comparison: Amgen Inc. vs Insmed Incorporated
Cost Insights: Breaking Down Amgen Inc. and Incyte Corporation's Expenses
Analyzing Cost of Revenue: BeiGene, Ltd. and PTC Therapeutics, Inc.
Incyte Corporation vs PTC Therapeutics, Inc.: Efficiency in Cost of Revenue Explored
Cost of Revenue: Key Insights for Insmed Incorporated and PTC Therapeutics, Inc.
Comparing Cost of Revenue Efficiency: Grifols, S.A. vs PTC Therapeutics, Inc.
Cost of Revenue: Key Insights for Amneal Pharmaceuticals, Inc. and PTC Therapeutics, Inc.
Cost of Revenue Trends: PTC Therapeutics, Inc. vs Vericel Corporation
Analyzing Cost of Revenue: PTC Therapeutics, Inc. and Celldex Therapeutics, Inc.